Mazyar Shadman, Mohamed Kharfan Dabaja
Dr. Mazyar Shadman is a blood cancer specialist who focuses on lymphoid malignancies. He is involved in clinical research using novel therapeutic agents for lymphoma and chronic lymphocytic leukemia, or CLL, as well as immunotherapy (specifically CAR T cell therapy) for lymphoid neoplasms and blood stem cell transplant for hematologic malignancies. His goal is to identify the best treatment sequence or combination for patients with high-risk lymphoma and CLL.
Dr. Mohamed Kharfan-Dabaja is a hematologist and oncologist at Mayo Clinic in Jacksonville, Florida, specializing in blood and marrow transplant and CAR-T therapy. He is involved in clinical research on novel cellular therapies and transplantation strategies for hematologic malignancies. Dr. Kharfan-Dabaja has published over 400 manuscripts and 21 book chapters and is fluent in Arabic, English, and Spanish.